Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-02
2011-08-02
Desai, Rita (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S284000, C548S407000
Reexamination Certificate
active
07989624
ABSTRACT:
The present invention is directed to compounds of Formula (I): where variables A1, A2, B, J, K, m, n, R4, R5a, R5b, R5cand X are as defined herein useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
REFERENCES:
patent: 7189722 (2007-03-01), Bell et al.
patent: 7192954 (2007-03-01), Bell et al.
patent: 7202251 (2007-04-01), Bell et al.
patent: 7390798 (2008-06-01), Williams et al.
patent: 7625901 (2009-12-01), Wood et al.
patent: 7629338 (2009-12-01), Wood et al.
patent: 7659300 (2010-02-01), Bell et al.
patent: 7696192 (2010-04-01), Bell et al.
patent: 2004/0063735 (2004-04-01), Chaturvedula et al.
patent: 2006/0189600 (2006-08-01), Bell et al.
patent: WO2004082605 (2004-09-01), None
patent: WO2004082678 (2004-09-01), None
patent: WO2004083187 (2004-09-01), None
patent: WO2004087649 (2004-10-01), None
patent: WO 2006/029153 (2006-03-01), None
patent: WO 2006/031610 (2006-03-01), None
patent: WO2006029153 (2006-03-01), None
patent: WO2006031491 (2006-03-01), None
Bell, Ian, et al.,—Abstract—AN 2006:269508.
Supplementary European Search Report, dated Dec. 30, 2009.
Pinder, et al., “2-Aminoindan-2-carboxylic Acids. Potential Tyrosine Hydroxylase Inhibitors,” Journal of Medicinal Chemistry, vol. 14, No. 9, 1971, pp. 892-893.
Bell Ian M.
Stump Craig A.
Theberge Cory R.
Desai Rita
Devlin Gerard M.
Merck Sharp & Dohme Corp.
Yuro Raynard
LandOfFree
Aryl spirolactam CGRP receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl spirolactam CGRP receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl spirolactam CGRP receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2758021